Concourse Financial Group Securities’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-168
Closed -$11.2K 1007
2024
Q4
$11.2K Sell
168
-375
-69% -$25.8K ﹤0.01% 1691
2024
Q3
$38.3K Hold
543
﹤0.01% 1280
2024
Q2
$36K Hold
543
﹤0.01% 1322
2024
Q1
$36.9K Buy
543
+165
+44% +$10.9K ﹤0.01% 1308
2023
Q4
$23.4K Hold
378
﹤0.01% 1443
2023
Q3
$22.4K Hold
378
﹤0.01% 1401
2023
Q2
$22.6K Hold
378
﹤0.01% 1402
2023
Q1
$22.1K Buy
378
+78
+26% +$4.7K ﹤0.01% 1428
2022
Q4
$18.6K Hold
300
﹤0.01% 1495
2022
Q3
$17K Sell
300
-2,190
-88% -$135K ﹤0.01% 1346
2022
Q2
$159K Sell
2,490
-2,130
-46% -$135K 0.01% 654
2022
Q1
$299K Buy
4,620
+2,550
+123% +$162K 0.02% 531
2021
Q4
$138K Hold
2,070
0.01% 866
2021
Q3
$126K Sell
2,070
-15
-0.7% -$954 0.01% 895
2021
Q2
$129K Buy
2,085
+171
+9% +$10.4K 0.01% 874
2021
Q1
$113K Sell
1,914
-5,454
-74% -$329K 0.01% 881
2020
Q4
$441K Sell
7,368
-62,340
-89% -$3.55M 0.03% 406
2020
Q3
$3.8M Buy
69,708
+67,395
+2,914% +$3.63M 0.33% 64
2020
Q2
$119K Sell
2,313
-312
-12% -$15.7K 0.01% 666
2020
Q1
$118K Sell
2,625
-45
-2% -$2.27K 0.01% 607
2019
Q4
$143K Buy
2,670
+222
+9% +$10.9K 0.01% 598
2019
Q3
$114K Sell
2,448
-591
-19% -$28.3K 0.03% 414
2019
Q2
$152K Sell
3,039
-15
-0.5% -$741 0.02% 547
2019
Q1
$156K Sell
3,054
-15,798
-84% -$786K 0.02% 560
2018
Q4
$884K Buy
18,852
+3,966
+27% +$203K 0.11% 169
2018
Q3
$835K Buy
+14,886
New +$813K 0.23% 93

Other funds holding IHE

Concourse Financial Group Securities's IHE Position: Q1 2025 in Review

Concourse Financial Group Securities sold out of iShares US Pharmaceuticals ETF (IHE) in Q1 2025, closing a stake of 168 shares — an estimated $11.2K sold.

Concourse Financial Group Securities first reported a position in IHE in Q3 2018 and held it in 26 quarters. The position peaked at $3.8M in Q3 2020. 149 funds tracked by Wall St. Rank hold IHE as of Q1 2025.

  • Concourse Financial Group Securities reported no remaining iShares US Pharmaceuticals ETF position as of Q1 2025 after selling out during the quarter.
  • Concourse Financial Group Securities sold 168 iShares US Pharmaceuticals ETF shares in Q1 2025, an estimated $11.2K.
  • Concourse Financial Group Securities first reported a position in iShares US Pharmaceuticals ETF in Q3 2018 and held it in 26 quarters.
  • Concourse Financial Group Securities's iShares US Pharmaceuticals ETF position peaked at $3.8M in Q3 2020.
  • 149 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q1 2025.

Based on Concourse Financial Group Securities's 13F filing for Q1 2025.